Emerging trends and utilization of patient-reported outcomes (PROs) in clinical trials of chimeric antigen receptor (CAR) T-cell therapies.

被引：0
作者：
Messina, Anthony John
Andrianov, Vasily
Mazzolenis, Daniel
Vidal-Fisher, Liat
机构：
[1] Syneos Hlth Oncol & Hematol, Port St Lucie, FL USA
[2] Syneos Hlth Oncol & Hematol, San Jose, CA USA
[3] Syneos Hlth Oncol & Hematol, Morrisville, NC USA
[4] Syneos Hlth Oncol & Hematol, Tel Aviv, Israel
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19142
引用
收藏
页数：1
相关论文
共 50 条
[31]   Chimeric Antigen Receptor T-Cell Therapies Advancing [J].
Brower, Vicki .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2016, 108 (11)
[32]   Patient-reported outcomes (PROs) in pancreatic cancer clinical trials (CTs) [J].
Grewal, Udhayvir Singh ;
Ahmed, Danya ;
Dhaliwal, Lovekirat Singh ;
Laheru, Daniel A. ;
Lou, Emil ;
Beg, Muhammad Shaalan ;
Nipp, Ryan David ;
Gupta, Arjun .
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
[33]   A universal suicide switch for chimeric antigen receptor T cell adoptive therapies. [J].
Smith, Julianne ;
Valton, Julien .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[34]   Emerging Trends in Chimeric Antigen Receptor T-Cell Immunotherapy in Adults from the Vizient Clinical Database [J].
Hartsell, Alyssa .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
[35]   Chimeric Antigen Receptor (CAR) T-cell Treatment in Renal Cell Carcinoma: Current Clinical Trials and Future Directions [J].
Lyou, Yung ;
Dorff, Tanya B. .
KIDNEY CANCER, 2022, 6 (03) :159-168
[36]   Advances in Chimeric Antigen Receptor (CAR) T-Cell Therapies for the Treatment of Primary Brain Tumors [J].
Mount, Christopher W. ;
Gonzalez Castro, Luis Nicolas .
ANTIBODIES, 2022, 11 (02)
[37]   Development of chimeric antigen receptor (CAR) T-cell immunotherapy [J].
Borchmann, P. .
ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 :27-27
[38]   Chimeric antigen receptor T-cell therapies: Optimising the dose [J].
Dasyam, Nathaniel ;
George, Philip ;
Weinkove, Robert .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 86 (09) :1678-1689
[39]   Early toxicity and clinical outcomes after chimeric antigen receptor T-cell (CAR-T) therapy for lymphoma [J].
Brammer, Jonathan E. ;
Braunstein, Zachary ;
Katapadi, Aashish ;
Porter, Kyle ;
Biersmith, Michael ;
Guha, Avirup ;
Vasu, Sumithira ;
Yildiz, Vedat O. ;
Smith, Sakima A. ;
Buck, Benjamin ;
Haddad, Devin ;
Gumina, Richard ;
William, Basem M. ;
Penza, Sam ;
Saad, Ayman ;
Denlinger, Nathan ;
Vallakati, Ajay ;
Baliga, Ragavendra ;
Benza, Raymond ;
Binkley, Philip ;
Wei, Lai ;
Mocarski, Mason ;
Devine, Steven M. ;
Jaglowski, Samantha ;
Addison, Daniel .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (08)
[40]   Chimeric antigen receptor T-cell therapies for multiple myeloma [J].
Mikkilineni, Lekha ;
Kochenderfer, James N. .
BLOOD, 2017, 130 (24) :2594-2602
12345